APP and Alzheimer disease: We cannot exclude that the overexpression of these proteins itself could also have influenced degradation, but importantly elevated C99 levels have also been reported in human AD post-mortem brains [18, 22, 42], indicating that C99 accumulation is not specific to mouse AD models, but also do occur in human AD.